Article Details

FDA Accepts Review of NDA for Vonoprazan From Phathom Pharmaceuticals

Retrieved on: 2022-06-03 17:05:01

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts Review of NDA for Vonoprazan From Phathom Pharmaceuticals. View article details on hiswai:

Excerpt

The drug is a treatment for individuals who are healing all grades of erosive esophagitis, as a relief of heartburn, and as maintenance of healing ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up